LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 90.55 | 27.76 | 958 | 6928 | 0.1383 | 0.5600 | MN20160318_Q01 | G16 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 90.55 | 27.76 | 9659 | 6928 | 1.3941 | 1.0852 | MN20160318_Q01 | G16 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 92.25 | 27.76 | 15 | 6873 | 0.0022 | -0.0745 | MN20160318_Q01 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 92.25 | 27.76 | 3485 | 6873 | 0.5070 | 0.8363 | MN20160318_Q01 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 92.25 | 27.76 | 833 | 6873 | 0.1212 | 0.5338 | MN20160318_Q01 | G16 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 92.25 | 27.76 | 9857 | 6873 | 1.4341 | 1.0928 | MN20160318_Q01 | G16 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 93.96 | 27.76 | 9 | 6849 | 0.0013 | -0.1322 | MN20160318_Q01 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 93.96 | 27.76 | 3029 | 6849 | 0.4423 | 0.8049 | MN20160318_Q01 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 93.96 | 27.76 | 864 | 6849 | 0.1262 | 0.5413 | MN20160318_Q01 | G16 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 93.96 | 27.76 | 10094 | 6849 | 1.4738 | 1.1000 | MN20160318_Q01 | G16 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 95.66 | 27.76 | 11 | 6712 | 0.0016 | -0.1103 | MN20160318_Q01 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 95.66 | 27.76 | 2582 | 6712 | 0.3847 | 0.7727 | MN20160318_Q01 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 95.66 | 27.76 | 707 | 6712 | 0.1053 | 0.5051 | MN20160318_Q01 | G16 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 95.66 | 27.76 | 10335 | 6712 | 1.5396 | 1.1120 | MN20160318_Q01 | G16 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 1.95 | 27.76 | 1 | 225 | 0.0044 | -0.6673 | MN20160318_Q01 | I15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 1.95 | 27.76 | 565 | 225 | 2.5095 | 1.7124 | MN20160318_Q01 | I15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 1.95 | 27.76 | 12 | 225 | 0.0533 | -0.2425 | MN20160318_Q01 | M03 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 1.95 | 27.76 | 536 | 225 | 2.3807 | 1.6655 | MN20160318_Q01 | M03 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 3.66 | 27.76 | 1 | 283 | 0.0035 | -0.6287 | MN20160318_Q01 | I15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 3.66 | 27.76 | 665 | 283 | 2.3421 | 1.5776 | MN20160318_Q01 | I15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 3.66 | 27.76 | 14 | 283 | 0.0493 | -0.1846 | MN20160318_Q01 | M03 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 3.66 | 27.76 | 633 | 283 | 2.2294 | 1.5400 | MN20160318_Q01 | M03 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 5.36 | 27.76 | 1 | 320 | 0.0031 | -0.6101 | MN20160318_Q01 | I15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 5.36 | 27.76 | 765 | 320 | 2.3880 | 1.5595 | MN20160318_Q01 | I15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 5.36 | 27.76 | 16 | 320 | 0.0499 | -0.1446 | MN20160318_Q01 | M03 |